Cargando…

Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma

BACKGROUND: Chemo-resistance in hepatocellular carcinoma (HCC) is a major problem, and acquired drug resistance prevents cancer therapies from achieving complete responses. Molecular targeting therapy presents an opportunity to impede tumor through combination or sequential therapy, while the accura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Xia, Song, Ge, Xu, Zihan, Bu, Yang, Chang, Fan, Jia, Fengan, Xiao, Xuelian, Ren, Xuejiao, Zhang, Mei, Jia, Qingan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958774/ https://www.ncbi.nlm.nih.gov/pubmed/31931755 http://dx.doi.org/10.1186/s12885-019-6480-9

Ejemplares similares

Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2019)

CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2019)

Inositol hexaphosphate sensitizes hepatocellular carcinoma to oxaliplatin relating inhibition of CCN2-LRP6-β-catenin-ABCG1 signaling pathway
por: Liao, Xia, et al.
Publicado: (2021)

WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer
por: Liao, Xia, et al.
Publicado: (2020)

Dual roles of WISP2 in the progression of hepatocellular carcinoma: implications of the fibroblast infiltration into the tumor microenvironment
por: Jia, Qingan, et al.
Publicado: (2021)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
por: Williams, Eleanor, et al.
Publicado: (2021)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Responses of Soil Rare and Abundant Sub-Communities and Physicochemical Properties after Application of Different Chinese Herb Residue Soil Amendments
por: Chang, Fan, et al.
Publicado: (2022)

Effects of rotation and Bacillus on the changes of continuous cropping soil fungal communities in American ginseng
por: Jia, Fengan, et al.
Publicado: (2023)

Effects of American Ginseng Cultivation on Bacterial Community Structure and Responses of Soil Nutrients in Different Ecological Niches
por: Chang, Fan, et al.
Publicado: (2022)

Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter
por: Xu, Ziyong, et al.
Publicado: (2022)

Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma
por: Li, Weimin, et al.
Publicado: (2019)

Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
por: Shin, Jin Soo, et al.
Publicado: (2018)

Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants
por: Thompson, Summer L., et al.
Publicado: (2021)

Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future
por: Liao, Xia, et al.
Publicado: (2019)

Herbal Compound “Songyou Yin” Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness
por: Jia, Qing-An, et al.
Publicado: (2012)

Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
por: Du, Guifang, et al.
Publicado: (2020)

Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1
por: Bu, Yang, et al.
Publicado: (2014)

Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancer
por: McGivern, Niamh, et al.
Publicado: (2017)

PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines
por: Nakachi, I, et al.
Publicado: (2016)

Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration
por: Gage, Meghan, et al.
Publicado: (2022)

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma
por: Heusschen, Roy, et al.
Publicado: (2016)

Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice
por: Luo, Xin-Ming, et al.
Publicado: (2021)

Depressive Disorder promotes Hepatocellular Carcinoma metastasis via upregulation of ABCG2 gene expression and maintenance of self-renewal
por: Hu, Hao, et al.
Publicado: (2020)

Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin
por: Cui, Wei, et al.
Publicado: (2017)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
por: Kaye, S, et al.
Publicado: (2012)

Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
por: Lang, Liwei, et al.
Publicado: (2018)

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
por: Fu, Xiu-Tao, et al.
Publicado: (2019)

Estrogen protects against liver damage in sepsis through inhibiting oxidative stress mediated activation of pyroptosis signaling pathway
por: Xu, Zihan, et al.
Publicado: (2020)

LOXL2 upregulates hypoxia-inducible factor-1α signaling through Snail-FBP1 axis in hepatocellular carcinoma cells
por: Fan, Zhiyong, et al.
Publicado: (2020)

Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells
por: Liao, Bo, et al.
Publicado: (2017)

Characterization of the Role of a Highly Conserved Sequence in ATP Binding Cassette Transporter G (ABCG) Family in ABCG1 Stability, Oligomerization, and Trafficking
por: Wang, Faqi, et al.
Publicado: (2013)

Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR‐195‐5p and ABCG2 pathway
por: Luo, Yaomin, et al.
Publicado: (2023)

Development of Simple and Accurate in Silico Ligand-Based Models for Predicting ABCG2 Inhibition
por: Huang, Shuheng, et al.
Publicado: (2022)

Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts
por: Harrach, Saliha, et al.
Publicado: (2017)

Upregulation of MiR-212 Inhibits Migration and Tumorigenicity and Inactivates Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
por: Jia, Pengbo, et al.
Publicado: (2018)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
por: Huang, Wei-Chien, et al.
Publicado: (2013)

Identification of ABCG2(+) cells in nasopharyngeal carcinoma cells
por: ZHANG, HONGBO, et al.
Publicado: (2011)

CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma?
por: Jia, Qingan, et al.
Publicado: (2015)

Relative roles of ABCG5/ABCG8 in liver and intestine
por: Wang, Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e08u5vmagqkp6tudtcgq61iscb